Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Top 3 Japanese Megabanks Reporting on November 13, 2026: Mitsubishi UFJ (NYSE:MUFG) EPS Estimate 0.34, Sumitomo Mitsui (NYSE:SMFG) EPS Estimate 0.4, Mizuho Financial (NYSE:MFG) EPS Estimate 0.17

Key Highlights0.34 is the consensus EPS estimate per the screener snapshot for Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG), against 0.4 for Sumitomo Mitsui and 0.17 for Mizuho, with all three call times listed as TNS and therefore unconfirmed.809.4 billion is the JPY first quarter …

Vinay Lochav | 12 November 2026

Why Did Gevo (NASDAQ:GEVO) Soar 30.94% on Record Revenue and a Raised EBITDA Outlook?

Key HighlightsGevo (NASDAQ:GEVO) closed up 30.94% on November 11, 2026, after reporting record third quarter results on November 10.Revenue was about USD 83 million, nearly double a year earlier, andNet Incomeattributable to Gevo was about USD 22.7 million, or USD 0.09 per share.About USD …

Vinay Lochav | 12 November 2026

How Did CuriosityStream (NASDAQ:CURI) Swing to a USD 4.8 Million Profit as Licensing Jumped 35%?

Gross profit was USD 10.1 million, a 49% margin, compared with USD 10.8 million and 59% a year earlier. The CFO said revenue sharing with content partners, which can reach 50% or more of a given deal, and amortization of barter programming explain the …

Vinay Lochav | 12 November 2026

Top 5 Largest Non-Japanese Earnings Reporters on November 13, 2026: Cosan S.A. (NYSE:CSAN) No EPS Estimate, Almonty Industries (NASDAQ:ALM) EPS Estimate 0.04, Twenty One Capital (NYSE:XXI) No EPS Estimate, Inhibrx Biosciences (NASDAQ:INBX) EPS Estimate -2.35, Americas Gold (NYSEAMERICAN:USAS) EPS Estimate 0.04

Key Highlights2.71 billion is the USD snapshotMarket Valueof Cosan S.A. (NYSE:CSAN), the largest of five, ahead of USD 2.32 billion at Almonty, USD 1.82 billion at Twenty OneCapitaland USD 1 billion at Americas Gold.0.04 is the consensus EPS estimate per the screener snapshot for …

Vinay Lochav | 12 November 2026

Why Did Fossil (NASDAQ:FOSL) Jump 26.68% on Raised Guidance and a Diesel License Extension?

The company raised its full year outlook. It now expects 2026 net sales of USD 980 million to USD 990 million, compared with prior guidance that called for a decline of 3% to 5%, an adjustedOperating Marginof 5.5% to 6.5%, up from 4% to …

Vinay Lochav | 12 November 2026

Is Dakota Gold (NYSEAMERICAN:DC) Cutting Its Loss to USD 8.4 Million While Holding USD 92.2 Million?

The company said it expects to finish its pre-feasibility study for the Richmond Hill project in the fourth quarter of 2026, with a feasibility study targeted for 2027. A metallurgical program reported on September 10 found that oxide lithologies other than transition material had …

Vinay Lochav | 12 November 2026

Top 5 Critical Minerals and Mining Stocks Reporting on November 13, 2026: Almonty Industries (NASDAQ:ALM) EPS Estimate 0.04, Americas Gold (NYSEAMERICAN:USAS) EPS Estimate 0.04, Talon Metals Corp. (OTCQX:TLOFF) EPS Estimate 0.04, Sigma Lithium (NASDAQ:SGML) EPS Estimate 0.08, Anfield Energy Inc. (NASDAQ:AEC) EPS Estimate -0.27

Key Highlights0.04 is the consensus EPS estimate per the screener snapshot for Almonty, Americas Gold and Talon Metals, while Sigma Lithium stands at 0.08 and Anfield Energy at a loss estimate of 0.27.2.32 billion is Almonty's USDMarket Valueper the screener snapshot, ahead of USD …

Vinay Lochav | 12 November 2026

Why Did Capricor (NASDAQ:CAPR) Jump 26.49% Ahead of Its November 22 FDA Decision?

On November 9, the company reported data from its HOPE-3 trial of 106 patients that met its primary upper limb endpoint at 12 months, and the shares rose 9.44%. Left ventricular ejection fraction favoured deramiocel by 1.8 points but missed statistical significance, with a …

Vinay Lochav | 12 November 2026

Can Dolphin Entertainment (NASDAQ:DLPN) Turn a Record USD 16.0 Million Quarter Into Lasting Profit?

Key HighlightsRevenue for the third quarter ended September 30, 2026 was a record USD 16.0 million, up 8.3% from USD 14.8 million, and management said growth would have been 9.7% excluding the spun-out Always Alpha.Net income was USD 0.23 million, or USD 0.02 per …

Vinay Lochav | 12 November 2026

Top 5 Clinical-Stage Biotech Stocks Reporting on November 13, 2026: Inhibrx Biosciences (NASDAQ:INBX) EPS Estimate -2.35, Immix Biopharma, Inc. (NASDAQ:IMMX) EPS Estimate -0.19, Eledon Pharmaceuticals (NASDAQ:ELDN) EPS Estimate -0.19, Immunic, Inc. (NASDAQ:IMUX) EPS Estimate -0.95, Neumora Therapeutics (NASDAQ:NMRA) EPS Estimate -0.19

Key Highlights0.19 is the loss per share expected for Immix Biopharma, Eledon and Neumora per the screener snapshot, versus a loss of 0.95 at Immunic and 2.35 at Inhibrx, with only Neumora under USD 100 million in market value.232.1 million is Immix's USD cash …

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…